Hypera Pharma
Corporate Profile
Hypera Pharma Corporate Profile
Hypera is Brazil’s largest pharmaceutical company and is present in all relevant segments of the industry. With a leading position in several categories, it offers high quality and safe products, continuously investing in innovation and growing in a sustainable way, so that people may live longer and better.

Hypera is organized into three major business units, leaders in the markets in which they are present:

Branded Prescription: Present in the main therapeutic classes in the country, it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa. It owns in this segment a portfolio of highly recognized medicines recommended by the medical community, with products such as Predsim, Celestamine, Maxsulid, Diprospan, Mioflex-A, Addera D3. In dermocosmetics, it acts as Mantecorp Skincare, with products recommended by dermatologists and developed especially for the characteristics of the Brazilian population. This business unit is supported by a highly productive medical visitation team, which conducts more than 200,000 doctor visits per month.

Consumer Health: Market leader in non-prescription drugs, with iconic brands recognized by Brazilians for decades, including Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, among others. The unit also operates in nutritionals and vitamin supplements, with brands such as Tamarine, Vitasay, Biotônico Fontoura and Zero-Cal, a Top-of-Mind brand for 14 consecutive years. It is the largest media investor in Brazil, with dozens of advertising campaigns each year in traditional and digital media.

Branded Generics: With the Neo Química brand, the Brazilian family’s medicine, the company has leadership in the Branded Generics and Generics markets in which it is present. Neo Química reaches more than 80% of households in Brazil, fulfilling its mission of promoting access to health with quality products for the population.

With future vision and innovation, Hypera has created Hynova, one of the largest and most modern pharmaceutical research centers in Brazil, which houses a team of highly qualified master-degree and Ph.D. professionals for the development of pharmaceuticals, dermocosmetics and health products, using state-of-the-art technology to be a pioneer in Brazil.

The strength of the company in the pharmaceutical market is supported by a large-scale, low-cost operation, centralized in the largest pharmaceutical operating complex in Latin America, located in Anápolis, Goiás.

Headquartered in São Paulo and listed on the Novo Mercado of BM&FBovespa since 2008, Hypera has a team of approximately 6,500 employees.

HYPERA 2002 - 2018 | Política de Privacidade | Assessoria de Imprensa | Código de ética | Responsabilidade Social

Av. Magalhães de Castro, 4800 - 24° andar - Edifício Continental Tower - Bairro Cidade Jardim - CEP 05676-120

SAC Medicamentos: 0800 97 99 900 - falecom-medicamentos@hypermarcas.com.br

SAC Consumo (Descartáveis, Cosméticos e Alimentos): 0800 011 1145 - falecom-consumo@hypermarcas.com.br


Linkedin YouTube